The Marcus (MCS) Q1 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2026 earnings summary
30 Apr, 2026Executive summary
Achieved year-over-year revenue and adjusted EBITDA growth in both theater and hotel divisions, outperforming industry benchmarks despite five fewer operating days due to a fiscal year change.
Theaters led growth with a strong film slate, improved attendance, and higher per capita sales; hotels benefited from renovated assets, new openings, and increased occupancy.
Operating loss improved to $19.3 million from $20.4 million, with net loss narrowing to $15.4 million from $16.8 million.
Adjusted EBITDA turned positive at $2.6 million, up from a loss of $0.3 million in the prior year quarter.
Momentum is expected to continue into spring and summer with anticipated film releases and travel season.
Financial highlights
Consolidated revenues reached $154.4 million, up 3.8% year-over-year; on a comparable calendar basis, revenues rose 15.6%.
Operating loss improved by $1.2 million to $19.3 million; adjusted EBITDA increased by $2.9 million to $2.6 million.
Free cash flow improved by $36.5 million year-over-year, aided by lower capital expenditures.
Net cash used in operating activities improved to $15.2 million from $35.3 million, mainly due to favorable working capital changes.
Capital expenditures decreased to $6.6 million from $23.0 million year-over-year.
Outlook and guidance
Expect continued growth in both divisions, supported by a robust upcoming film slate and strong group bookings in hotels.
Capital expenditures for 2026 projected at $50–$55 million, with anticipated significant free cash flow increase.
Effective income tax rate for fiscal 2026 is expected to be in the 32%-34% range.
Group room revenue bookings for hotels are running about 5% ahead of last year, with banquet and catering revenue pace stable or ahead for 2026 and 2027.
Management remains optimistic about long-term industry prospects and is prepared to adjust to economic uncertainties.
Latest events from The Marcus
- Both divisions outperformed peers in 2025, with strong revenue growth and a robust 2026 outlook.MCS
Q4 20258 Apr 2026 - Annual meeting to vote on directors, executive pay, auditor, and highlight ESG and governance.MCS
Proxy filing7 Apr 2026 - Virtual annual meeting to vote on directors, pay, and auditor ratification, all board-backed.MCS
Proxy filing7 Apr 2026 - 2025 revenue reached $758.5M with strong theatre and hotel performance and robust growth outlook.MCS
Investor presentation5 Mar 2026 - Q2 revenue dropped 15%, but hotels outperformed and group bookings surged as theatres rebounded.MCS
Q2 20242 Feb 2026 - Record Q3 revenue, earnings, and industry outperformance with a strengthened capital structure.MCS
Q3 202417 Jan 2026 - Q4 revenue up 16.6% and record hotel results, with strong momentum for 2025 growth.MCS
Q4 202423 Dec 2025 - Shelf registration enables up to $150M in securities offerings and 5M-share secondary sales.MCS
Registration Filing16 Dec 2025 - Annual meeting to vote on directors, incentive plan, executive pay, and auditor ratification.MCS
Proxy Filing2 Dec 2025